Search details
1.
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
Cell
; 183(5): 1264-1281.e20, 2020 11 25.
Article
in English
| MEDLINE | ID: mdl-33091337
2.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nat Immunol
; 22(1): 74-85, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32999467
3.
Targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 623(7988): 820-827, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37938771
4.
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Nature
; 592(7854): 463-468, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33762734
5.
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 599(7885): 477-484, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34732890
6.
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 566(7745): E13, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30733620
7.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 565(7738): 240-245, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30568303
8.
The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif.
PLoS Biol
; 19(4): e3001057, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33901176
9.
The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.
EMBO Rep
; 23(12): e55470, 2022 12 06.
Article
in English
| MEDLINE | ID: mdl-36215666
10.
Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 623(7988): 872, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37938785
11.
Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
Mol Cell Proteomics
; 19(3): 432-443, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31937595
12.
Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
J Proteome Res
; 20(1): 289-304, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-33141586
13.
Improved Ribo-seq enables identification of cryptic translation events.
Nat Methods
; 15(5): 363-366, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29529017
14.
HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.
PLoS Pathog
; 15(9): e1008040, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31527904
15.
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.
Blood
; 133(6): 550-565, 2019 02 07.
Article
in English
| MEDLINE | ID: mdl-30530751
16.
A vaccine targeting mutant IDH1 induces antitumour immunity.
Nature
; 512(7514): 324-7, 2014 Aug 21.
Article
in English
| MEDLINE | ID: mdl-25043048
17.
The SysteMHC Atlas project.
Nucleic Acids Res
; 46(D1): D1237-D1247, 2018 01 04.
Article
in English
| MEDLINE | ID: mdl-28985418
18.
The immunopeptidomic landscape of ovarian carcinomas.
Proc Natl Acad Sci U S A
; 114(46): E9942-E9951, 2017 11 14.
Article
in English
| MEDLINE | ID: mdl-29093164
19.
MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics.
J Proteome Res
; 18(11): 3876-3884, 2019 11 01.
Article
in English
| MEDLINE | ID: mdl-31589052
20.
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
J Proteome Res
; 18(6): 2666-2675, 2019 06 07.
Article
in English
| MEDLINE | ID: mdl-31095916